PHARMACEUTICAL container specialist Tower Cold Chain is celebrating after being honoured with a King’s Award for Enterprise in the Innovation category.
The accolade follows the Queen’s Award for International Trade the company won in 2022.
The business, which manufactures temperature-controlled containers for the transportation of life-science and biotech products, has earned the King’s Award for Innovation in recognition of its KTM container – a thermally insulated passive pallet shipping system, with a patented modular construction design.
Tower had to demonstrate outstanding commercial success over two years, attributable to the KTM. The company explained that ‘extensive’ investment enabled it to scale production of the KTM at the beginning of the decade, a period that also coincided with the outbreak of the Covid-19 pandemic, when the KTM was widely used by pharmaceutical manufacturers to ship vaccines globally.
The KTM is said to have filled a gap in the cold chain shipping market, with its design striking a balance between volumetric ‘efficiency, durability, and optimised weight’ Tower added.
“To win any King or Queen’s Award requires the highest standards, so for Tower Cold Chain to receive awards in two consecutive years is a fantastic achievement,” said CEO Niall Balfour. “With our industry-leading product, it is an incredible honour to receive such recognition for the KTM range as we continue to work with global pharmaceutical manufacturers, airlines and third-party logistics customers to deliver products to patients in a robust, reliable, reusable method.”
